Literature DB >> 8333766

Resting energy expenditure and substrate oxidation rates in cystic fibrosis.

I M Bowler1, J H Green, S P Wolfe, J M Littlewood.   

Abstract

The resting energy expenditure (REE) and substrate oxidation rates in 16 patients with cystic fibrosis who had mild chest disease and 11 healthy controls were measured using indirect calorimetry. The mean REE (% predicted) in the patients with cystic fibrosis was 11% greater than in the controls. Five patients with cystic fibrosis were hypermetabolic but only one of these had a clinically significant reduction of respiratory function. A greater proportion of REE was derived from carbohydrate oxidation in the cystic fibrosis patients (43.5% v 29.9%). However, the 24 hour dietary intake of carbohydrate was greater in the cystic fibrosis group (49.6 v 45.8% of energy intake). These data suggest that a high dietary intake of carbohydrate may contribute to the increased oxidation of carbohydrate in these cystic fibrosis patients. All patients with cystic fibrosis, including those with apparently mild lung disease, should continue to receive a high energy diet.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333766      PMCID: PMC1029368          DOI: 10.1136/adc.68.6.754

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  38 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Assessment of total energy expenditure in free-living patients with cystic fibrosis.

Authors:  V Spicher; M Roulet; Y Schutz
Journal:  J Pediatr       Date:  1991-06       Impact factor: 4.406

3.  Prevalence of liver disease in cystic fibrosis.

Authors:  R Scott-Jupp; M Lama; M S Tanner
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

4.  Glucose tolerance in cystic fibrosis.

Authors:  S Lanng; B Thorsteinsson; G Erichsen; J Nerup; C Koch
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

5.  Enhanced intestinal glucose and alanine transport in cystic fibrosis.

Authors:  P Baxter; J Goldhill; J Hardcastle; P T Hardcastle; C J Taylor
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Are patients with primary biliary cirrhosis hypermetabolic? A comparison between patients before and after liver transplantation and controls.

Authors:  J H Green; P N Bramley; M S Losowsky
Journal:  Hepatology       Date:  1991-09       Impact factor: 17.425

8.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Increased energy expenditure in cystic fibrosis is associated with specific mutations.

Authors:  A O'Rawe; I McIntosh; J A Dodge; D J Brock; A O Redmond; R Ward; A J Macpherson
Journal:  Clin Sci (Lond)       Date:  1992-01       Impact factor: 6.124

10.  The cystic fibrosis gene and resting energy expenditure.

Authors:  M D Fried; P R Durie; L C Tsui; M Corey; H Levison; P B Pencharz
Journal:  J Pediatr       Date:  1991-12       Impact factor: 4.406

View more
  3 in total

1.  Absence of leptin signaling allows fat accretion in cystic fibrosis mice.

Authors:  Ilya R Bederman; Gavriella Pora; Maureen O'Reilly; James Poleman; Kimberly Spoonhower; Michelle Puchowicz; Aura Perez; Bernadette O Erokwu; Alex Rodriguez-Palacios; Chris A Flask; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-08-17       Impact factor: 4.052

2.  Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis.

Authors:  P Vic; S Ategbo; F Gottrand; V Launay; G A Loeuille; J C Elian; D Druon; J P Farriaux; D Turck
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

3.  Ventilatory pattern and energy expenditure are altered in cystic fibrosis mice.

Authors:  Rebecca J Darrah; Ilya R Bederman; Anna L Mitchell; Craig A Hodges; Cara K Campanaro; Mitchell L Drumm; Frank J Jacono
Journal:  J Cyst Fibros       Date:  2013-01-03       Impact factor: 5.482

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.